90 niner

LeBron James lets his jealousy show during Savannah James' dance and moves on her TikTok video

Eagles seek 7th straight win while Rams try to keep pace in crowded NFC West raceGreat British Bake Off fans left divided as winner of 2024 series is crowned

Uncover How One Tech Giant’s Success is Shaping the Future of Electronics

Stephanie Armour, Julie Rovner | (TNS) KFF Health News Many of President-elect Donald Trump’s candidates for federal health agencies have promoted policies and goals that put them at odds with one another or with Trump’s choice to run the Department of Health and Human Services, Robert F. Kennedy Jr., setting the stage for internal friction over public health initiatives. Related Articles National Politics | Biden will decide on US Steel acquisition after influential panel fails to reach consensus National Politics | Biden vetoes once-bipartisan effort to add 66 federal judgeships, citing ‘hurried’ House action National Politics | An analyst looks ahead to how the US economy might fare under Trump National Politics | Trump again calls to buy Greenland after eyeing Canada and the Panama Canal National Politics | House Ethics Committee accuses Gaetz of ‘regularly’ paying for sex, including with 17-year-old girl The picks hold different views on matters such as limits on abortion, the safety of childhood vaccines, the COVID-19 response, and the use of weight-loss medications. The divide pits Trump picks who adhere to more traditional and orthodox science, such as the long-held, scientifically supported findings that vaccines are safe, against often unsubstantiated views advanced by Kennedy and other selections who have claimed vaccines are linked with autism. The Trump transition team and the designated nominees mentioned in this article did not respond to requests for comment. It’s a potential “team of opponents” at the government’s health agencies, said Michael Cannon, director of health policy studies at the Cato Institute, a libertarian policy organization. Kennedy, he said, is known for rejecting opposing views when confronted with science. “The heads of the FDA and NIH will be spending all their time explaining to their boss what a confidence interval is,” Cannon said, referring to a statistical term used in medical studies. Those whose views prevail will have significant power in shaping policy, from who is appointed to sit on federal vaccine advisory committees to federal authorization for COVID vaccines to restrictions on abortion medications. If confirmed as HHS secretary, Kennedy is expected to set much of the agenda. “If President Trump’s nomination of RFK Jr. to be secretary is confirmed, if you don’t subscribe to his views, it will be very hard to rise in that department,” said Amesh Adalja, an infectious disease specialist and senior scholar at the Johns Hopkins Center for Health Security. “They will need to suppress their views to fit with RFK Jr’s. In this administration, and any administration, independent public disagreement isn’t welcome.” Kennedy is chair of Children’s Health Defense , an anti-vaccine nonprofit. He has vowed to curb the country’s appetite for ultra-processed food and its incidence of chronic disease. He helped select Trump’s choices to lead the Centers for Disease Control and Prevention, the Food and Drug Administration, and the National Institutes of Health. If confirmed, he would lead them from the helm of HHS, with its more than $1.7 trillion budget. Clashes are likely. Kennedy has supported access to abortion until a fetus is viable. That puts him at odds with Dave Weldon, the former Florida congressman whom Trump has chosen to run the CDC. Weldon, a physician, is an abortion opponent who wrote one of the major laws allowing health professionals to opt out of participating in the procedure. Weldon would head an agency that’s been in the crosshairs of conservatives since the COVID pandemic began. He has touted his “100% pro-life voting record” on his campaign website. (He unsuccessfully ran earlier this year for a seat in Florida’s House of Representatives.) Trump has said he would leave decisions about abortion to the states, but the CDC under Weldon could, for example, fund studies on abortion risks. The agency could require states to provide information about abortions performed within their borders to the federal government or risk the loss of federal funds. Weldon, like Kennedy, has questioned the safety of vaccines and has said he believes they can cause autism. That’s at odds with the views of Marty Makary, a Johns Hopkins surgeon whom Trump plans to nominate for FDA commissioner. The British American said on the “Brian Kilmeade Show” on Fox News Radio that vaccines “save lives,” although he added that it’s good to question the U.S. vaccine schedule for children. The American Academy of Pediatricians encourages parents and their children’s doctors to stick to the recommended schedule of childhood vaccines. “Nonstandard schedules that spread out vaccines or start when a child is older put entire communities at risk of serious illnesses, including infants and young children,” the group says in guidance for its members. Jay Bhattacharya, a doctor and economist who is Trump’s selection to lead NIH, has also supported vaccines. Kennedy has said on NPR that federal authorities under his leadership wouldn’t “take vaccines away from anybody.” But the FDA oversees approval of vaccines, and, under his leadership, the agency could put vaccine skeptics on advisory panels or could make changes to a program that largely protects vaccine makers from consumer injury lawsuits. “I do believe that autism does come from vaccines,” Kennedy said in 2023 on Fox News . Many scientific studies have discredited the claim that vaccines cause autism. Ashish Jha, a doctor who served as the White House COVID response coordinator from 2022 to 2023, noted that Bhattacharya and Makary have had long and distinguished careers in medicine and research and would bring decades of experience to these top jobs. But, he said, it “is going to be a lot more difficult than they think” to stand up for their views in the new administration. It’s hard “to do things that displease your boss, and if [Kennedy] gets confirmed, he will be their boss,” Jha said. “They have their work cut out for them if they’re going to stand up for their opinions on science. If they don’t, it will just demoralize the staff.” Most of Trump’s picks share the view that federal health agencies bungled the pandemic response, a stance that resonated with many of the president-elect’s voters and supporters — even though Trump led that response until Joe Biden took office in 2021. Kennedy said in a 2021 Louisiana House oversight meeting that the COVID vaccine was the “deadliest” ever made. He has cited no evidence to back the claim. Federal health officials say the vaccines have saved millions of lives around the globe and offer important protection against COVID. Protection lasts even though their effectiveness wanes over time. The vaccines’ effectiveness against infection stood at 52% after four weeks, according to a May study in The New England Journal of Medicine, and their effectiveness against hospitalization was about 67% after four weeks. The vaccines were produced through Operation Warp Speed, a public-private partnership Trump launched in his first term to fast-track the shots as well as other treatments. Makary criticized COVID vaccine guidance that called for giving young children the shots. He argued that, for many people, natural immunity from infections could substitute for the vaccine. Bhattacharya opposed measures used to curb the spread of COVID in 2020 and advised that everyone except the most vulnerable go about their lives as usual. The World Health Organization warned that such an approach would overwhelm hospitals. Mehmet Oz, Trump’s choice to head the Centers for Medicare & Medicaid Services, an agency within HHS, has said the vaccines were oversold. He promoted the use of the anti-malaria drug hydroxychloroquine as a treatment. The FDA in 2020 revoked emergency authorization of hydroxychloroquine for COVID, saying that it was unlikely to be effective against the virus and that the risk of dangerous side effects was too high. Janette Nesheiwat, meanwhile, a former Fox News contributor and Trump’s pick for surgeon general, has taken a different stance. The doctor described COVID vaccines as a gift from God in a Fox News opinion piece . Kennedy’s qualms about vaccines are likely to be a central issue early in the administration. He has said he wants federal health agencies to shift their focus from preparing for and combating infectious disease to addressing chronic disease. The shifting focus and questioning of vaccines concern some public health leaders amid the spread of the H5N1 bird flu virus among dairy cattle. There have been 60 human infections reported in the U.S. this year, all but two of them linked to exposure to cattle or poultry. “Early on, they’re going to have to have a discussion about vaccinating people and animals” against bird flu, said Georges C. Benjamin, executive director of the American Public Health Association. “We all bring opinions to the table. A department’s cohesive policy is driven by the secretary.” ©2024 KFF Health News. Distributed by Tribune Content Agency, LLC.Seventeenth Acquisition In 2024: Mutares Has Signed An Agreement To Acquire GDL Anläggning & Miljö AB From GDL Transport Holding AB

Michael Grados, formerly of Johnstown, will be competing in this weekend’s Masters Swimming National in Warsaw, Poland. Grados, now living in Syracuse, New York, is seeded fifth in advance of the 100-meter butterfly, with a qualifying time of 59.28 seconds. Grados, who is representing Water Squad, is also slated to compete in the 50 and 100 freestyle events, the 50 butterfly, the 100 individual medley and various relays. (c)2024 The Tribune-Democrat (Johnstown, Pa.) Visit The Tribune-Democrat (Johnstown, Pa.) at www.tribune-democrat.com Distributed by Tribune Content Agency, LLC.Noodles and wine are the secret ingredients for a strange new twist in China's doping saga

Trump’s picks for top health jobs not just team of rivals but ‘team of opponents’NORAD’s Santa tracker was a Cold War morale boost. Now it attracts millions of kids

Review: It’s alright, Ma — Dylan biopic works better than many fearedDelta Air Lines is one of the largest and most well-known carriers in all of aviation, and, while simple, its mainline livery is effective and recognizable. Indeed, the red logo and dark blue accents are more than enough for most people to identify an aircraft as belonging to Delta, even at a short glance. However, the airline has also painted certain aircraft in more colorful liveries to support various causes. Supporting Team USA In recent years, the most conspicuous special liveries in Delta's fleet have arguably been those offering support to Team USA at the Olympic and Paralympic Games. As it happens, the Atlanta-headquartered US legacy carrier and SkyTeam founding member is the official airline of the American team for these events, managing travel for the summer games in 2024 and 2028 and the winter games in 2026. Want answers to more key questions in aviation? Check out the rest of our guides here ! Delta Air Lines has underlined the importance of this partnership by devising special Team USA liveries for not one but two of its aircraft. Furthermore, the planes used are both examples of the carrier's newest widebody designs, meaning that its message of support for the team is spread on a large platform, and the use of such new aircraft allows this to be done in a modern and forward-thinking manner. The first of the two aircraft to get its special Team USA livery was an Airbus A330-900 from the multinational European planemaker's new A330neo series. According to Airport Spotting , the plane in question bears the registration N411DX, with fleet data from ATDB.aero showing that it received its special paint scheme in December of 2021. Notably, the Team USA branding is larger than that of Delta itself. Earlier this year, Delta Air Lines added a second aircraft to its growing fleet of Team USA-liveried planes, with an A350-900 registered as N521DN getting the nod. According to Delta , the scheme was unveiled at the start of May in Toulouse, just in time for the 2024 Paris Olympics and Paralympics . The design is similar to that of the A330-900, but has a greater emphasis on the colors of the US flag. Raising awareness for breast cancer While Delta's connections to Team USA go back several years, the airline has an even more longstanding special livery partnership on its books in the form of the Breast Cancer Research Foundation. According to the Delta Flight Museum , this agreement stretches as far back as 2005, when a Boeing 757 flown by Delta's low-cost subsidiary Song was painted in a pink design to support the BCRF. This aircraft, which bore the registration N610DL, retained a pink livery in support of the Breast Cancer Research Foundation when it was transferred to Delta's mainline fleet. This lasted until 2010, at which point the carrier opted to switch the aircraft used to raise awareness for breast cancer to one from its widebody stable. In the end, it opted for a Boeing 767-400ER, which bore the registration N845MH. As pictured below, the BCRF-themed livery that this aircraft first received in June 2010 was largely the same as Delta's mainline paint scheme, just with its tail, engines and belly painted pink instead of the usual blue and red tones. However, a closer look at the front of the aircraft's fuselage also reveals details such as the slogan 'Force For Global Good' and the signature of BCRF founder Evelyn Lauder. After more than five years of raising awareness in this manner, Delta Air Lines decided in 2015 that it was time for N845MH to receive a fresh coat of pink paint. As a result, in September of that year, the aircraft's existing BCRF livery was replaced with a new one that saw the aircraft return to the usual blue and red engine, belly, and tail accents, but daubed with a large and elegant pink ribbon down its fuselage. Saying thank you The intention behind most special liveries is to mark a commercial partnership or relationship involving the airline in question. However, every now and then, it is the time and place for a dash of well-earned self-indulgence, such as when Delta Air Lines celebrated reporting a record $1.6 billion profit-sharing payout to its employees back in February of 2020 by devising a corresponding special livery. As pictured above, the scheme in question featured an Airbus A321 registered as N391DN, and, at face value, appeared to consist of 'Thank You' written in large red letters along the fuselage. However, upon closer inspection, it becomes evident that these letters featured the names of all 90,000 of its employees at the time. The scheme was " dedicated to the world's best customers and employees ." Celebrating alliance membership As a founding member of the SkyTeam alliance, Delta Air Lines is rightfully proud of its membership in this select group of some of the world's leading carriers. The Delta Flight Museum notes that, in March of 2009, the airline became the first SkyTeam member to paint an aircraft in the alliance's unified silver and dark blue paint scheme, which has now become widespread among its members worldwide. As pictured above, aircraft types to have worn the SkyTeam livery at Delta Air Lines include the Boeing 737, 757, and 767. At present, Airport Spotting reports that the paint scheme can be found on three Boeing 737-800s (N3758Y, N3761R, and N381DN) and one 767-400ER (N844MH). Going forward, Aviation A2Z notes that the carrier is planning a special 100th-anniversary livery for next year.Enter the World of 'Solo Leveling: Unlimited (SL:U)': Where Hunters Become Collectors

Harris: Fine Gael ‘will gain seats’ amid further fragmentation of Irish politics

‘Like watching robots’: Administrators struggle to limit cell phones in school

Global Software Quality Assurance and Testing Service Market Size, Share and Forecast By Key Players-Altoros, Avenga, BairesDev, BlastAsia, ByteAnt 12-24-2024 06:20 PM CET | Advertising, Media Consulting, Marketing Research Press release from: Market Research Intellect Software Quality Assurance and Testing Service Market USA, New Jersey- According to the Market Research Intellect, the global Software Quality Assurance and Testing Service market is projected to grow at a robust compound annual growth rate (CAGR) of 15.77% from 2024 to 2031. Starting with a valuation of 6.84 Billion in 2024, the market is expected to reach approximately 16.47 Billion by 2031, driven by factors such as Software Quality Assurance and Testing Service and Software Quality Assurance and Testing Service. This significant growth underscores the expanding demand for Software Quality Assurance and Testing Service across various sectors. The Software Quality Assurance (QA) and Testing Service market has experienced significant growth, driven by the increasing demand for high-quality software in industries such as IT, healthcare, finance, and e-commerce. As organizations face the complexity of developing robust applications, the need for comprehensive QA and testing solutions has intensified. The growing adoption of agile methodologies, along with the rise of automation testing tools, has further fueled market expansion. Additionally, the increasing focus on reducing operational risks and improving user experience has heightened the demand for effective QA processes. As businesses increasingly prioritize seamless, error-free software, the market for software testing services is expected to continue its upward trajectory, with innovations like AI-driven testing playing a crucial role in shaping the future. The dynamics of the Software Quality Assurance and Testing Service market are shaped by various factors, such as technological advancements, market competition, and evolving customer expectations. The integration of automation, artificial intelligence, and machine learning into testing processes has revolutionized the industry, offering faster and more accurate results. Additionally, the shift toward cloud-based platforms allows for scalable and cost-effective testing solutions. However, challenges such as the growing complexity of software systems, the need for skilled professionals, and budget constraints continue to impact the market. Despite these challenges, the growing reliance on software for business-critical applications and the demand for faster time-to-market solutions are driving innovation and competitive pressure in the QA and testing services market. Request PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.marketresearchintellect.com/download-sample/?rid=10777400&utm_source=OpenPr&utm_medium=047 Key Drivers: The growth of the Software Quality Assurance and Testing Service market is driven by several key factors. Technological advancements in Software Quality Assurance and Testing Service have enabled greater efficiency and enhanced capabilities, spurring adoption across industries. Additionally, the rising demand for sustainable and eco-friendly solutions is pushing companies to innovate and adopt greener practices. Expanding applications in sectors like Software Quality Assurance and Testing Service and Software Quality Assurance and Testing Service are further contributing to market demand, as these industries seek advanced solutions to streamline operations and enhance product quality. Favorable government policies and incentives in regions such as North America, Europe, and Asia-Pacific support investment and growth. Moreover, an increasing focus on Software Quality Assurance and Testing Service for improving operational efficiency and cost-effectiveness is encouraging businesses to embrace new technologies, fostering sustained market expansion. Mergers and Acquisitions Mergers and acquisitions (M&A) play a pivotal role in the Software Quality Assurance and Testing Service market, as companies look to expand their capabilities, access new technologies, and strengthen market presence. Leading players engage in strategic acquisitions to consolidate their position and gain a competitive edge. These transactions often facilitate the integration of advanced Software Quality Assurance and Testing Service solutions, helping firms broaden their product portfolios and meet growing customer demands. Additionally, M&A activities support companies in achieving economies of scale and penetrating new regional markets, particularly in high-growth areas like Asia-Pacific. Through such strategic alliances, businesses aim to accelerate innovation, enhance operational efficiency, and address evolving market challenges, ultimately driving the overall growth of the Software Quality Assurance and Testing Service market. Get a Discount On The Purchase Of This Report @ https://www.marketresearchintellect.com/ask-for-discount/?rid=10777400&utm_source=OpenPr&utm_medium=047 The following Key Segments Are Covered in Our Report By Type Security Testing Usability Testing Functional Testing Localization Testing Compatibility Testing Others By Application SaaS Testing Web Application Testing Mobile Application Testing Desktop Application Testing Others Major companies in Software Quality Assurance and Testing Service Market are: Altoros, Avenga, BairesDev, BlastAsia, ByteAnt, Capgemini, Elinext, Evoke Technologies, FortySeven, Globant (Belatrix), Hidden Brains Infotech, Intertek, Itransition, Kanda Software, Litslink, Net Solutions, nResult, NTT (NTT Data), Orient Software, Oxagile, QASource, QAT Global, Romexsoft, ScienceSoft, ScriptSmart, SDLC Partners, Softtek, TatvaSoft, TietoEVRY, Vilmate Global Software Quality Assurance and Testing Service Market -Regional Analysis North America: North America is expected to hold a significant share of the Software Quality Assurance and Testing Service market due to advanced technological infrastructure and the presence of major market players. High demand across sectors like Software Quality Assurance and Testing Service and Software Quality Assurance and Testing Service is driving growth, with the U.S. being a key contributor. Additionally, ongoing investments in R&D and innovation reinforce the region's strong market position. Europe: Europe is projected to experience steady growth, driven by stringent regulatory standards and a rising focus on sustainability in Software Quality Assurance and Testing Service practices. Countries like Germany, France, and the UK are leading due to their advanced industrial base and supportive government policies. The demand for eco-friendly and efficient Software Quality Assurance and Testing Service solutions is expected to continue fostering market expansion. Asia-Pacific: Asia-Pacific is anticipated to be the fastest-growing region, fueled by rapid industrialization and urbanization. Countries such as China, India, and Japan are driving demand due to expanding consumer bases and increasing investments in infrastructure. The region's robust manufacturing sector and favorable economic policies further enhance growth opportunities in the Software Quality Assurance and Testing Service market. Latin America: Latin America and the Middle East & Africa are expected to show moderate growth in the Software Quality Assurance and Testing Service market. In Latin America, growth is supported by rising industrial activities in countries like Brazil and Mexico. Meanwhile, in the Middle East & Africa, infrastructure development and an increasing focus on innovation in sectors like Software Quality Assurance and Testing Service are key drivers of market expansion. Middle East and Africa: The Middle East and Africa represent emerging markets in the global Software Quality Assurance and Testing Service market, with countries like UAE, Saudi Arabia, South Africa, and Nigeria showing promising growth potential. Economic diversification efforts, urbanization, and a young population are driving demand for Software Quality Assurance and Testing Service products and services in the region. Frequently Asked Questions (FAQ) 1. What is the current size of the Software Quality Assurance and Testing Service market? Answer: The Software Quality Assurance and Testing Service market was valued at approximately 6.84 Billion in 2024, with projections suggesting it will reach 16.47 Billion by 2031, growing at a CAGR of 15.77%. 2. What factors are driving the growth of the Software Quality Assurance and Testing Service market? Answer: The market's expansion is attributed to several factors, including increased demand for Software Quality Assurance and Testing Service, advancements in Software Quality Assurance and Testing Service technology, and the adoption of Software Quality Assurance and Testing Service across various sectors. 3. Which regions are expected to dominate the Software Quality Assurance and Testing Service market? Answer: Regions such as North America, Europe, and Asia-Pacific are anticipated to lead due to the presence of major industry players and growing investments in Software Quality Assurance and Testing Service. 4. Who are the key players in the Software Quality Assurance and Testing Service market? Answer: Prominent companies in the Software Quality Assurance and Testing Service market include Software Quality Assurance and Testing Service, Software Quality Assurance and Testing Service, and Software Quality Assurance and Testing Service, each contributing to market growth through innovations and strategic partnerships. 5. What challenges does the Software Quality Assurance and Testing Service market face? Answer: The market faces challenges such as Software Quality Assurance and Testing Service, regulatory compliance, and competition from alternative solutions. However, ongoing advancements aim to address these issues. 6. What are the future trends in the Software Quality Assurance and Testing Service market? Emerging trends include the integration of Software Quality Assurance and Testing Service technology, sustainability practices, and digital transformation in processes, all expected to shape the market's future. 7. How can businesses benefit from the Software Quality Assurance and Testing Service market? Answer: Businesses can leverage growth opportunities in the Software Quality Assurance and Testing Service market by adopting new solutions, enhancing operational efficiency, and expanding their offerings to meet evolving consumer demands. 8. Why invest in a Software Quality Assurance and Testing Service market report from MRI? Answer: MRI's report provides in-depth analysis, future projections, and key insights to support strategic decision-making, enabling businesses to stay competitive and capitalize on growth trends in the Software Quality Assurance and Testing Service market. For More Information or Query, Visit @ https://www.marketresearchintellect.com/product/software-quality-assurance-and-testing-service-market/?utm_source=OpenPr&utm_medium=047 About Us: Market Research Intellect Market Research Intellect is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions. Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research. Our research spans a multitude of industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverages, etc. Having serviced many Fortune 2000 organizations, we bring a rich and reliable experience that covers all kinds of research needs. For inquiries, Contact Us at: Mr. Edwyne Fernandes Market Research Intellect APAC: +61 485 860 968 EU: +44 788 886 6344 US: +1 743 222 5439 This release was published on openPR.Expert calls Trump taunts ‘churlish’, urges Canada to focus on coming trade war